837 related articles for article (PubMed ID: 19307157)
21. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
[TBL] [Abstract][Full Text] [Related]
22. Assessment of serum level of interleukin-1b and interleukin-12 in leprosy: impact of previous Bacillus Calmitte Guerin vaccination.
Sallam MA; Attia EA; Soliman MS
Arch Dermatol Res; 2014 Mar; 306(2):189-95. PubMed ID: 24022478
[TBL] [Abstract][Full Text] [Related]
23. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
[TBL] [Abstract][Full Text] [Related]
24. Complement C1q expression in Erythema nodosum leprosum.
Negera E; Walker SL; Lema T; Aseffa A; Lockwood DN; Dockrell HM
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006321. PubMed ID: 29499046
[TBL] [Abstract][Full Text] [Related]
25. Some unusual type 2 reactions in leprosy.
Ramesh V; Pahwa M
Int J Dermatol; 2010 Feb; 49(2):172-5. PubMed ID: 20465641
[TBL] [Abstract][Full Text] [Related]
26. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
Foss NT; de Oliveira EB; Silva CL
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
[TBL] [Abstract][Full Text] [Related]
27. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
[TBL] [Abstract][Full Text] [Related]
28. Thalidomide levels in patients with erythema nodosum leprosum.
Vieira JL; Valente Mdo S
Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
[TBL] [Abstract][Full Text] [Related]
29. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
Hungria EM; Oliveira RM; Penna GO; Aderaldo LC; Pontes MA; Cruz R; Gonçalves HS; Penna ML; Kerr LR; Stefani MM; Bührer-Sékula S
Infect Dis Poverty; 2016 Dec; 5(1):110. PubMed ID: 27919284
[TBL] [Abstract][Full Text] [Related]
30. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
31. Development of giant reaction in response to PPD skin test in lepromatous leprosy patients.
Sampaio EP; Duppre NC; Nery JA; Moreira AL; Sarno EN
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):205-13. PubMed ID: 8371029
[TBL] [Abstract][Full Text] [Related]
32. Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions.
Chakrabarty AK; Kashyap A; Sehgal VN; Saha K
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):559-65. PubMed ID: 3221112
[TBL] [Abstract][Full Text] [Related]
33. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
34. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
[TBL] [Abstract][Full Text] [Related]
35. alpha1-acid glycoprotein as a putative biomarker for monitoring the development of the type II reactional stage of leprosy.
Gupta N; Shankernarayan NP; Dharmalingam K
J Med Microbiol; 2010 Apr; 59(Pt 4):400-407. PubMed ID: 20075114
[TBL] [Abstract][Full Text] [Related]
36. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
Kumar A; Girdhar A; Girdhar BK
Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
[TBL] [Abstract][Full Text] [Related]
37. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
[TBL] [Abstract][Full Text] [Related]
38. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
[TBL] [Abstract][Full Text] [Related]
39. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
Modlin RL; Gebhard JF; Taylor CR; Rea TH
Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
[TBL] [Abstract][Full Text] [Related]
40. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
